Virus Induced Lymphocytes (VIL) as a novel viral antigen-specific T cell therapy for COVID-19 and potential future pandemics

The a priori T cell repertoire and immune response against SARS-CoV-2 viral antigens may explain the varying clinical course and prognosis of patients having a mild COVID-19 infection as opposed to those developing more fulminant multisystem organ failure and associated mortality. Using a novel SARS...

Descripción completa

Detalles Bibliográficos
Autores principales: Sivapalan, Rohan, Liu, Jinyan, Chakraborty, Krishnendu, Arthofer, Elisa, Choudhry, Modassir, Barie, Philip S., Barouch, Dan H., Henley, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316478/
https://www.ncbi.nlm.nih.gov/pubmed/34315945
http://dx.doi.org/10.1038/s41598-021-94654-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8316478/
https://www.ncbi.nlm.nih.gov/pubmed/34315945
http://dx.doi.org/10.1038/s41598-021-94654-y

Ejemplares similares